How can health care professionals explain biosimilars? An assessment of a mock consultation involving ‘family-centered’ communication.

Not Applicable

Completed

• Conditions: Health-related decision making; Patient-provider-companion communication; Public Health - Health promotion/education

• Registration Number: ACTRN12621001103853
• Lead Sponsor: Professor Keith Petrie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-08-18
• Study Completion: 2022-03-31
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

All participants must be 18 years of age or over, able to fill out the questionnaires, willing to participate, and fluent in the English language. Participants and companions must have known each other for at least six months.

Exclusion Criteria

Any participants who are unable to fill out the questionnaires, are unwilling to participate, and/or cannot understand, read, or write English will be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patients' willingness to transition from a bio-originator drug to a biosimilar assessed using a binary response (Yes/No).[Immediately post-intervention.]